TherapeuticsMD reported $-1.77M in EBIT for its fiscal quarter ending in September of 2023.





Ebit Change Date
AbbVie USD 6.72B 1.99B Jun/2026
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Cipla INR 8.88B 2.74B Jun/2026
Clal Biotechnology ILS -5.44M 3.76M Dec/2022
Compugen USD -9.02M 65.06M Mar/2026
CSL USD 2.64B 116M Dec/2025
Grifols EUR 320.55M 91.01M Dec/2025
Novo Nordisk DKK 5.25B 60.42B Jun/2026
Pfizer USD -180M 5.16B Jun/2026
TherapeuticsMD USD -1.77M 699K Sep/2023